product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Phospho-NMDAR1 (Ser890) Antibody
catalog :
3381S
quantity :
100 ul
price :
274 USD
clonality :
polyclonal
host :
rabbit
antigen modification :
phosphorylated
reactivity :
human, mouse, rat
application :
western blot, immunohistochemistry, immunocytochemistry, immunoprecipitation, immunohistochemistry - frozen section
citations: 3
Published Application/Species/DilutionReference
  • western blot; mouse; 1:1000; fig 6
Posa L, Accarie A, Noble F, Marie N. Methadone Reverses Analgesic Tolerance Induced by Morphine Pretreatment. Int J Neuropsychopharmacol. 2016;19: pubmed publisher
  • western blot; mouse; fig 7
Garzón J, Herrero-Labrador R, Rodríguez-Muñoz M, Shah R, Vicente-Sánchez A, Wagner C, et al. HINT1 protein: a new therapeutic target to enhance opioid antinociception and block mechanical allodynia. Neuropharmacology. 2015;89:412-23 pubmed
  • western blot; mouse; 1:1000; fig 9
  • immunoprecipitation; mouse; fig 9
Rodríguez-Muñoz M, Sánchez-Blázquez P, Vicente-Sánchez A, Bailón C, Martín-Aznar B, Garzón J. The histidine triad nucleotide-binding protein 1 supports mu-opioid receptor-glutamate NMDA receptor cross-regulation. Cell Mol Life Sci. 2011;68:2933-49 pubmed publisher
product information
SKU :
3381S
Product-Name :
Phospho-NMDAR1 (Ser890) Antibody
Size :
100 ul
Price-(USD) :
274 USD
Species-x-Reactivity :
H, M, R
Applications :
Immunofluorescence (Frozen)
Product-Category :
Neuroscience
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
120
Host :
Rabbit
Target :
NMDAR1 (Ser890) phosphate
Primary-Protein :
NMDAR1
Alt-Names :
GRIN1,Glutamate [NMDA] receptor subunit zeta-1,N-methyl-D-aspartate receptor channel, subunit zeta-1,N-methyl-D-aspartate receptor subunit NR1,NMD-R1,NMDA1,NMDAR1,NMDZ1,NR1,glutamate [NMDA] receptor subunit zeta 1,glutamate receptor, ionotropic, N-methyl D-aspartate 1
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.